Abbona, A.; Ricci, V.; Paccagnella, M.; Granetto, C.; Ruatta, F.; Cauchi, C.; Galizia, D.; Ghidini, M.; Denaro, N.; Merlano, M.C.;
et al. Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines 2023, 11, 335.
https://doi.org/10.3390/vaccines11020335
AMA Style
Abbona A, Ricci V, Paccagnella M, Granetto C, Ruatta F, Cauchi C, Galizia D, Ghidini M, Denaro N, Merlano MC,
et al. Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines. 2023; 11(2):335.
https://doi.org/10.3390/vaccines11020335
Chicago/Turabian Style
Abbona, Andrea, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Carolina Cauchi, Danilo Galizia, Michele Ghidini, Nerina Denaro, Marco Carlo Merlano,
and et al. 2023. "Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib" Vaccines 11, no. 2: 335.
https://doi.org/10.3390/vaccines11020335
APA Style
Abbona, A., Ricci, V., Paccagnella, M., Granetto, C., Ruatta, F., Cauchi, C., Galizia, D., Ghidini, M., Denaro, N., Merlano, M. C., & Garrone, O.
(2023). Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. Vaccines, 11(2), 335.
https://doi.org/10.3390/vaccines11020335
